A comparison of the myocardial metabolic and haemodynamic changes produced by propofol-sufentanil and enflurane-sufentanil anaesthesia for patients having coronary artery bypass graft surgery

Can J Anaesth. 1991 Nov;38(8):996-1004. doi: 10.1007/BF03008618.

Abstract

The purpose of this study was to compare propofol-sufentanil with enflurane-sufentanil anaesthesia for patients undergoing elective coronary artery bypass graft (CABG) surgery with respect to changes in (1) haemodynamic variables; (2) myocardial blood flow and metabolism; (3) serum cortisol, triglyceride, lipoprotein concentrations and liver function; and (4) recovery characteristics. Forty-seven patients with preserved ventricular function (ejection fraction greater than 40%, left ventricular end diastolic pressure less than or equal to 16 mmHg) were studied. Patients in Group A (n = 24) received sufentanil 0.2 microgram.kg-1 and propofol 1-2 mg.kg-1 for induction of anaesthesia which was maintained with a variable rate propofol (50-200 micrograms.kg-1.min-1) infusion and supplemental sufentanil (maximum total 5 micrograms.kg-1). Patients in Group B (n = 23) received sufentanil 5 micrograms.kg-1 for induction of anaesthesia which was maintained with enflurane and supplemental sufentanil (maximum total 7 micrograms.kg-1). Haemodynamic and myocardial metabolic profiles were determined at the awake-sedated, post-induction, post-intubation, first skin incision, post-sternotomy, and pre-cardiopulmonary bypass intervals. Induction of anaesthesia produced a larger reduction in systolic blood pressure in Group A (156 +/- 22 to 104 +/- 20 mmHg vs 152 +/- 26 to 124 +/- 24 mmHg; P less than 0.05). No statistical differences were detected at any other time or in any other variable including myocardial lactate production (n = 13 events in each group), time to tracheal extubation and time to discharge from the ICU. We concluded that, apart from hypotension on induction of anaesthesia, propofol-sufentanil anaesthesia produced anaesthetic conditions equivalent to enflurane-sufentanil anaesthesia for CABG surgery.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anesthesia Recovery Period
  • Anesthesia, Inhalation*
  • Anesthesia, Intravenous*
  • Anesthetics / pharmacology*
  • Coronary Artery Bypass*
  • Coronary Circulation / drug effects
  • Enflurane / pharmacology*
  • Female
  • Fentanyl / analogs & derivatives*
  • Fentanyl / pharmacology
  • Heart / drug effects*
  • Hemodynamics / drug effects
  • Humans
  • Hydrocortisone / blood
  • Lipoproteins, HDL / blood
  • Liver / metabolism
  • Male
  • Middle Aged
  • Myocardium / metabolism*
  • Propofol / pharmacology*
  • Prospective Studies
  • Sufentanil
  • Triglycerides / blood

Substances

  • Anesthetics
  • Lipoproteins, HDL
  • Triglycerides
  • Enflurane
  • Sufentanil
  • Fentanyl
  • Hydrocortisone
  • Propofol